About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Transcriptomics Market Size, Trends & Growth Analysis Report | 2032
Transcriptomics Market

Transcriptomics Market Size, Share & Trends Analysis Report By Type (Instruments, Consumables, Software & Services), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Others), By Applications (Drug Discovery and Development, Diagnostics and Disease Profiling, Others), By End User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI2123DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Transcriptomics Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Development
        1. By Value
      3. Diagnostics and Disease Profiling
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Development
        1. By Value
      3. Diagnostics and Disease Profiling
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Development
          1. By Value
        3. Diagnostics and Disease Profiling
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Development
        1. By Value
      3. Diagnostics and Disease Profiling
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Development
          1. By Value
        3. Diagnostics and Disease Profiling
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Development
        1. By Value
      3. Diagnostics and Disease Profiling
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Development
          1. By Value
        3. Diagnostics and Disease Profiling
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Development
        1. By Value
      3. Diagnostics and Disease Profiling
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Development
          1. By Value
        3. Diagnostics and Disease Profiling
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Instruments
        1. By Value
      3. Consumables
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
      5. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery and Development
        1. By Value
      3. Diagnostics and Disease Profiling
        1. By Value
      4. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Academic and Research Institutes
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Instruments
          1. By Value
        3. Consumables
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
        5. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery and Development
          1. By Value
        3. Diagnostics and Disease Profiling
          1. By Value
        4. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Academic and Research Institutes
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Transcriptomics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Pacific Biosciences of California Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. Agilent Technologies Inc.
    4. Illumina Inc.
    5. QIAGEN
    6. Bio-Rad Laboratories Inc.
    7. Takara Bio Inc.
    8. PerkinElmer Inc.
    9. Fluidigm Corporation
    10. F-Hoffmann La-Roche
    11. Merck & Co. Inc
    12. Promega Corporation
    13. RNA Connect
    14. Becton, Dickinson and Company
    15. Bio-Techne Corporation
    16. Others
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Transcritical CO2 Market Size The Transcritical CO2 market size was valued at USD 49.79 Billion in 2024. It is expected to reach from USD 49.79 Billion in 2025 to USD 203.01 Billion by 2033, growing at a CAGR of 16.9% during the forec
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.